T

Tiziana Life Sciences Ltd
D

TLSA

0.82630
USD
-0.06
(-7.19%)
مغلق
حجم التداول
600
الربح لكل سهم
-0
العائد الربحي
-
P/E
-6
حجم السوق
85,788,733
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AAPL
    AAPL
    -0.310
    (-0.13%)
    245.560 USD
    AMZN
    AMZN
    -6.305
    (-2.83%)
    216.495 USD
    F
    F
    -0.09500
    (-1.01%)
    9.29000 USD
    GM
    GM
    -1.570
    (-3.28%)
    46.310 USD
    MSFT
    MSFT
    -7.96
    (-1.91%)
    408.15 USD
    N
    NIO
    0.07500
    (1.72%)
    4.44500 USD
    N
    NKLA
    -0.05810
    (-13.20%)
    0.38200 USD
    المزيد
الأخبار
المقالات

العنوان: Tiziana Life Sciences Ltd

القطاع: Healthcare
الصناعة: Biotechnology
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.